Top Key Companies for At-Home Drug of Abuse (DOA) Testing Market: UCP Biosciences, Orient New Life Medical, Express Diagnostics Int’l, Assure Tech (Hangzhou), Psychemedics Corporation, Confirm BioSciences, Phamatech, Home Health (U.K.) Ltd., Quest Products.
Global At-Home Drug of Abuse (DOA) Testing Market Research Report: 2024-2035 Outlook with Market Insights, Industry and Competitive Analysis Included. Remarkable growth trajectory projected.
Global At-Home Drug of Abuse (DOA) Testing Market Overview And Scope:
The Global At-Home Drug of Abuse (DOA) Testing Market Report 2026 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of At-Home Drug of Abuse (DOA) Testing utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2024 and 2035. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Global At-Home Drug of Abuse (DOA) Testing Market Segmentation
By Type, At-Home Drug of Abuse (DOA) Testing market has been segmented into:
Test Cups
Test Dip Cards
Test Strips
Others
By Application, At-Home Drug of Abuse (DOA) Testing market has been segmented into:
Urine
Saliva
Hair
Others
Regional Analysis of At-Home Drug of Abuse (DOA) Testing Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of At-Home Drug of Abuse (DOA) Testing Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The At-Home Drug of Abuse (DOA) Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the At-Home Drug of Abuse (DOA) Testing market.
Top Key Companies Covered in At-Home Drug of Abuse (DOA) Testing market are:
UCP Biosciences
Orient New Life Medical
Express Diagnostics Int’l
Assure Tech (Hangzhou)
Psychemedics Corporation
Confirm BioSciences
Phamatech
Home Health (U.K.) Ltd.
Quest Products
Key Questions answered in the At-Home Drug of Abuse (DOA) Testing Market Report:
1. What is the expected At-Home Drug of Abuse (DOA) Testing Market size during the forecast period, 2025-2032?
2. Which region is the largest market for the At-Home Drug of Abuse (DOA) Testing Market?
3. What is the expected future scenario and the revenue generated by different regions and countries in the At-Home Drug of Abuse (DOA) Testing Market, such as North America, Europe, AsiaPacific & Japan, China, U.K., South America, and Middle East and Africa?
4. What is the competitive strength of the key players in the At-Home Drug of Abuse (DOA) Testing Market on the basis of the analysis of their recent developments, product offerings, and regional presence?
5. Where do the key At-Home Drug of Abuse (DOA) Testing companies lie in their competitive benchmarking compared to the factors of market coverage and market potential?
6. How are the adoption scenario, related opportunities, and challenges impacting the At-Home Drug of Abuse (DOA) Testing Markets?
7. How is the funding and investment landscape in the At-Home Drug of Abuse (DOA) Testing Market?
8. Which are the leading consortiums and associations in the At-Home Drug of Abuse (DOA) Testing Market, and what is their role in the market?
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: At-Home Drug of Abuse (DOA) Testing Market by Type
5.1 At-Home Drug of Abuse (DOA) Testing Market Overview Snapshot and Growth Engine
5.2 At-Home Drug of Abuse (DOA) Testing Market Overview
5.3 Test Cups
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2024-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Test Cups: Geographic Segmentation
5.4 Test Dip Cards
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2024-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Test Dip Cards: Geographic Segmentation
5.5 Test Strips
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2024-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Test Strips: Geographic Segmentation
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2024-2035F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others: Geographic Segmentation
Chapter 6: At-Home Drug of Abuse (DOA) Testing Market by Application
6.1 At-Home Drug of Abuse (DOA) Testing Market Overview Snapshot and Growth Engine
6.2 At-Home Drug of Abuse (DOA) Testing Market Overview
6.3 Urine
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2024-2035F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Urine: Geographic Segmentation
6.4 Saliva
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2024-2035F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Saliva: Geographic Segmentation
6.5 Hair
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2024-2035F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Hair: Geographic Segmentation
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2024-2035F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 At-Home Drug of Abuse (DOA) Testing Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 At-Home Drug of Abuse (DOA) Testing Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 At-Home Drug of Abuse (DOA) Testing Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 UCP BIOSCIENCES
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 ORIENT NEW LIFE MEDICAL
7.4 EXPRESS DIAGNOSTICS INT’L
7.5 ASSURE TECH (HANGZHOU)
7.6 PSYCHEMEDICS CORPORATION
7.7 CONFIRM BIOSCIENCES
7.8 PHAMATECH
7.9 HOME HEALTH (U.K.) LTD.
7.10 QUEST PRODUCTS
Chapter 8: Global At-Home Drug of Abuse (DOA) Testing Market Analysis, Insights and Forecast, 2024-2035
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Test Cups
8.2.2 Test Dip Cards
8.2.3 Test Strips
8.2.4 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Urine
8.3.2 Saliva
8.3.3 Hair
8.3.4 Others
Chapter 9: North America At-Home Drug of Abuse (DOA) Testing Market Analysis, Insights and Forecast, 2024-2035
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Test Cups
9.4.2 Test Dip Cards
9.4.3 Test Strips
9.4.4 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Urine
9.5.2 Saliva
9.5.3 Hair
9.5.4 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe At-Home Drug of Abuse (DOA) Testing Market Analysis, Insights and Forecast, 2024-2035
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Test Cups
10.4.2 Test Dip Cards
10.4.3 Test Strips
10.4.4 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Urine
10.5.2 Saliva
10.5.3 Hair
10.5.4 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe At-Home Drug of Abuse (DOA) Testing Market Analysis, Insights and Forecast, 2024-2035
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Test Cups
11.4.2 Test Dip Cards
11.4.3 Test Strips
11.4.4 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Urine
11.5.2 Saliva
11.5.3 Hair
11.5.4 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific At-Home Drug of Abuse (DOA) Testing Market Analysis, Insights and Forecast, 2024-2035
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Test Cups
12.4.2 Test Dip Cards
12.4.3 Test Strips
12.4.4 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Urine
12.5.2 Saliva
12.5.3 Hair
12.5.4 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Analysis, Insights and Forecast, 2024-2035
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Test Cups
13.4.2 Test Dip Cards
13.4.3 Test Strips
13.4.4 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Urine
13.5.2 Saliva
13.5.3 Hair
13.5.4 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America At-Home Drug of Abuse (DOA) Testing Market Analysis, Insights and Forecast, 2024-2035
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Test Cups
14.4.2 Test Dip Cards
14.4.3 Test Strips
14.4.4 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Urine
14.5.2 Saliva
14.5.3 Hair
14.5.4 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
At-Home Drug of Abuse (DOA) Testing Scope:
|
Report Data
|
At-Home Drug of Abuse (DOA) Testing Market
|
|
At-Home Drug of Abuse (DOA) Testing Market Size in 2025
|
USD XX million
|
|
At-Home Drug of Abuse (DOA) Testing CAGR 2025 - 2032
|
XX%
|
|
At-Home Drug of Abuse (DOA) Testing Base Year
|
2024
|
|
At-Home Drug of Abuse (DOA) Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
UCP Biosciences, Orient New Life Medical, Express Diagnostics Int’l, Assure Tech (Hangzhou), Psychemedics Corporation, Confirm BioSciences, Phamatech, Home Health (U.K.) Ltd., Quest Products.
|
|
Key Segments
|
By Type
Test Cups Test Dip Cards Test Strips Others
By Applications
Urine Saliva Hair Others
|